Shoichi Mizuno

3.4k total citations
103 papers, 2.6k citations indexed

About

Shoichi Mizuno is a scholar working on Oncology, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Shoichi Mizuno has authored 103 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 18 papers in Physiology and 16 papers in Pathology and Forensic Medicine. Recurrent topics in Shoichi Mizuno's work include Global Cancer Incidence and Screening (9 papers), Immunotherapy and Immune Responses (9 papers) and Diet, Metabolism, and Disease (8 papers). Shoichi Mizuno is often cited by papers focused on Global Cancer Incidence and Screening (9 papers), Immunotherapy and Immune Responses (9 papers) and Diet, Metabolism, and Disease (8 papers). Shoichi Mizuno collaborates with scholars based in Japan, United Kingdom and United States. Shoichi Mizuno's co-authors include Shaw Watanabe, Melissa K. Melby, Yukako Tatsumi, Akiko Morimoto, Yuko Ohno, Tetsuya Nakatsura, Toshiaki Yoshikawa, Kyoko Taku, Tomotaka Sobue and Yoshiko Ishimi and has published in prestigious journals such as Cancer, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Shoichi Mizuno

99 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shoichi Mizuno Japan 27 705 536 514 380 316 103 2.6k
Hong Cheng China 26 501 0.7× 735 1.4× 484 0.9× 339 0.9× 171 0.5× 137 2.5k
Bo Zhou China 28 399 0.6× 555 1.0× 319 0.6× 219 0.6× 216 0.7× 106 2.4k
Elizabeth M. Poole United States 36 1.3k 1.8× 835 1.6× 379 0.7× 295 0.8× 315 1.0× 134 3.6k
Karen L. Koenig United States 33 1.0k 1.4× 861 1.6× 514 1.0× 157 0.4× 208 0.7× 71 3.4k
Chad Deal United States 27 1.1k 1.6× 1.2k 2.2× 371 0.7× 172 0.5× 194 0.6× 62 3.9k
Sandra C. Hoffman United States 32 611 0.9× 1.1k 2.1× 260 0.5× 192 0.5× 148 0.5× 54 3.3k
Marco Montella Italy 34 1.0k 1.5× 401 0.7× 395 0.8× 508 1.3× 94 0.3× 121 2.8k
Hisashi Masuyama Japan 31 558 0.8× 689 1.3× 205 0.4× 134 0.4× 342 1.1× 164 3.1k
Pierluigi Cocco Italy 27 454 0.6× 303 0.6× 433 0.8× 526 1.4× 168 0.5× 99 2.5k
Chen Yuan China 31 851 1.2× 930 1.7× 241 0.5× 519 1.4× 252 0.8× 121 3.3k

Countries citing papers authored by Shoichi Mizuno

Since Specialization
Citations

This map shows the geographic impact of Shoichi Mizuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoichi Mizuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoichi Mizuno more than expected).

Fields of papers citing papers by Shoichi Mizuno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoichi Mizuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoichi Mizuno. The network helps show where Shoichi Mizuno may publish in the future.

Co-authorship network of co-authors of Shoichi Mizuno

This figure shows the co-authorship network connecting the top 25 collaborators of Shoichi Mizuno. A scholar is included among the top collaborators of Shoichi Mizuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoichi Mizuno. Shoichi Mizuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akiyama, Tomoko, et al.. (2024). Effects and Safety of the 7th Diet of Original Macrobiotics. Acta Scientifci Nutritional Health. 52–56. 1 indexed citations
2.
Mizuno, Shoichi, Toshiaki Yoshikawa, Motokazu Sugimoto, et al.. (2020). Peptide vaccine as an adjuvant therapy for glypican‐3‐positive hepatocellular carcinoma induces peptide‐specific CTLs and improves long prognosis. Cancer Science. 111(8). 2747–2759. 26 indexed citations
3.
Kawahara, Tetsuya, Gen Suzuki, Tetsuya Inazu, et al.. (2016). Rationale and design of Diabetes Prevention with active Vitamin D (DPVD): a randomised, double-blind, placebo-controlled study. BMJ Open. 6(7). e011183–e011183. 19 indexed citations
4.
Tsuboyama-Kasaoka, Nobuyo, et al.. (2014). What factors were important for dietary improvement in emergency shelters after the Great East Japan Earthquake?. PubMed. 23(1). 159–66. 39 indexed citations
5.
Morimoto, Akiko, Yukako Tatsumi, Shoichi Mizuno, et al.. (2013). Impact of impaired insulin secretion and insulin resistance on the incidence of type 2 diabetes mellitus in a Japanese population: the Saku study. Diabetologia. 56(8). 1671–1679. 87 indexed citations
6.
Sawada, Yu, Toshiaki Yoshikawa, Daisuke Nobuoka, et al.. (2012). Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival. Clinical Cancer Research. 18(13). 3686–3696. 251 indexed citations
7.
Morimoto, Akiko, et al.. (2012). Impact of cigarette smoking on impaired insulin secretion and insulin resistance in Japanese men: The Saku Study. Journal of Diabetes Investigation. 4(3). 274–280. 40 indexed citations
8.
Miyaoka, Tsuyoshi, Rei Yasukawa, Shoichi Mizuno, et al.. (2005). Fluid-attenuated inversion-recovery MR imaging in schizophrenia-associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). European Psychiatry. 20(4). 327–331. 17 indexed citations
9.
Mizuno, Shoichi, Hidemi Ito, Nobuyuki Hamajima, et al.. (2004). Association between Smoking Habits and Tryptophan Hydroxylase Gene C218A Polymorphism among the Japanese Population. Journal of Epidemiology. 14(3). 94–99. 6 indexed citations
10.
Miyaoka, Tsuyoshi, Rei Yasukawa, Yoshiko Shimizu, et al.. (2003). Successful Electroconvulsive Therapy in Major Depression With Fluvoxamine-Induced Bruxism. Journal of Ect. 19(3). 170–172. 10 indexed citations
11.
Moriyama, Sachiko, Mitsugu Hironaka, Takeshi Fujii, et al.. (1999). p16 inactivation in small-sized lung adenocarcinoma: Its association with poor prognosis. International Journal of Cancer. 84(1). 49–53. 34 indexed citations
12.
Akiba, Suminori, et al.. (1996). Cancer Mortality in Minamata Disease Patients Exposed to Methymercu Through Fish Diet. Journal of Epidemiology. 6(3). 134–138. 18 indexed citations
13.
Sasaki, Yasutsuna, Hideo Hakusui, Shoichi Mizuno, et al.. (1995). A Pharmacokinetic and Pharmacodynamic Analysis of CPT‐11 and Its Active Metabolite SN‐38. Japanese Journal of Cancer Research. 86(1). 101–110. 60 indexed citations
14.
Watanabe, Shaw, Shoichi Mizuno, Yukiko Tsunematsu, et al.. (1994). Leukemia in GH Deficient Children. Clinical Pediatric Endocrinology. 3(Supple5). 53–60. 3 indexed citations
16.
Matsuno, Yoshihiro, et al.. (1994). Surgically Curable “Early” Adenocarcinoma in the Periphery of the Lung. The American Journal of Surgical Pathology. 18(5). 431–438. 76 indexed citations
17.
Mizuno, Shoichi, Naohito Yamaguchi, & Shaw Watanabe. (1992). Cancer Mortality Trends in Japan 1960–1990: Three-dimensional Graphical Presentation. Japanese Journal of Clinical Oncology. 22(6). 433–6. 8 indexed citations
19.
Mizuno, Shoichi & Suminori Akiba. (1989). Smoking and Lung Cancer Mortality in Japanese Men: Estimates for Dose and Duration of Cigarette Smoking Based on the Japan Vital Statistics Data. Japanese Journal of Cancer Research. 80(8). 727–731. 10 indexed citations
20.
Mizuno, Shoichi, Suminori Akiba, & Takeshi Hirayama. (1989). Lung Cancer Risk Comparison among Male Smokers between the “Six‐prefecture Cohort” in Japan and the British Physicians' Cohort. Japanese Journal of Cancer Research. 80(12). 1165–1170. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026